We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
- Authors
Giannelli, Gianluigi; Santoro, Armando; Kelley, Robin K.; Gane, Ed; Paradis, Valerie; Cleverly, Ann; Smith, Claire; Estrem, Shawn T.; Man, Michael; Wang, Shuaicheng; Lahn, Michael M.; Raymond, Eric; Benhadji, Karim A.; Faivre, Sandrine
- Abstract
There is an error in affiliation 2 for the second author Armando Santoro. Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF- RI inhibitor galunisertib Reference 1 Giannelli G, Santoro A, Kelley RK, Gane E, Paradis V, et al. (2020) Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF- RI inhibitor galunisertib.
- Subjects
OVERALL survival; HEPATOCELLULAR carcinoma; BIOMARKERS; MEDICAL research; MEDICAL sciences
- Publication
PLoS ONE, 2021, Vol 16, Issue 6, p1
- ISSN
1932-6203
- Publication type
Correction Notice
- DOI
10.1371/journal.pone.0253671